Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Total article views   Abstract views HTML views PDF downloads Totals
13,467 Dovepress* 11,859 852+ 960 12,711
PubMed Central* 0 756 266 756
Totals 11,859 1,608 1,226 13,467
*Since 4 September 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar